Pickhardt Perry J, Edwards Kristin, Bruining David H, Gollub Marc, Kupfer Sonja, Lubner Sam J, Kim David H, Ross Eric, Keenan Eileen, Weinberg David S
1 University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin 2 Fox Chase Cancer Center, Philadelphia, Pennsylvania 3 Mayo Clinic, Rochester, Minnesota 4 Memorial Sloan-Kettering Cancer Center, New York, New York 5 University of Chicago Medical Center, Chicago, Illinois.
Dis Colon Rectum. 2017 Nov;60(11):1162-1167. doi: 10.1097/DCR.0000000000000845.
The aim of this study was to compare the accuracy of CT colonography versus optical colonoscopy for neoplastic involvement at the surgical anastomosis 1 year after curative-intent colorectal cancer resection.
DESIGN, SETTING, PATIENTS, AND INTERVENTIONS: Two hundred one patients (mean age, 58.6 years; 117 men, 84 women) underwent same-day contrast-enhanced CT colonography and colonoscopy approximately 1 year (mean, 12.1 months; median, 11.9 months) after colorectal cancer resection as part of a prospective, multicenter trial. All patients enrolled were without clinical evidence of disease and considered low risk for recurrence (stage I-III).
Suspected neoplastic lesions within 5 cm of the colonic anastomosis were recorded at CT colonography, with subsequent colonoscopy performed for the same, with segmental unblinding of colonography findings. Anastomotic region biopsy or polypectomy was performed at the endoscopist's discretion.
None of the 201 patients had intraluminal anastomotic cancer recurrence or advanced neoplasia (or metachronous cancers). CT colonography detected extramural perianastomotic recurrence in 2 patients (1.0%); neither was detected at colonoscopy. Only 2 patients (1.0%; 2/201) were called positive at CT colonography for intraluminal anastomotic nondiminutive lesions (7- to 8-mm polyps), which were confirmed at colonoscopy but nonneoplastic at histopathology. At optical colonoscopy, the anastomosis was deemed abnormal and/or biopsied in 10.0% (20/201), yielding only 1 nondiminutive benign neoplasm (7-mm tubular adenoma).
The lack of luminal cancer recurrence in our lower-risk cohort precludes assessment of sensitivity for detection, rendering the study underpowered in this regard. Potential cost savings of combined CT/CT colonography over the standard CT/colonoscopy approach were not assessed.
Relevant intraluminal anastomotic pathology appears to be very uncommon 1 year after colorectal cancer resection in lower-risk cohorts. Unlike colonoscopy, diagnostic contrast-enhanced CT colonography effectively evaluates both the intra- and extraluminal aspects of the anastomosis. See Video Abstract at http://links.lww.com/DCR/A471.
本研究旨在比较在根治性结直肠癌切除术后1年时,CT结肠成像与光学结肠镜检查对手术吻合口肿瘤累及情况的诊断准确性。
设计、场所、患者及干预措施:作为一项前瞻性多中心试验的一部分,201例患者(平均年龄58.6岁;男性117例,女性84例)在结直肠癌切除术后约1年(平均12.1个月;中位数11.9个月)接受了同日对比增强CT结肠成像和结肠镜检查。所有入组患者均无疾病的临床证据,且被认为复发风险较低(I - III期)。
在CT结肠成像中记录结肠吻合口5 cm范围内可疑的肿瘤性病变,随后进行结肠镜检查以评估相同部位,并对结肠成像结果进行分段解盲。内镜医师可自行决定对吻合口区进行活检或息肉切除术。
201例患者均未出现腔内吻合口癌复发或进展期肿瘤(或异时性癌)。CT结肠成像检测到2例患者(1.0%)存在壁外吻合口复发;结肠镜检查均未发现。在CT结肠成像中,只有2例患者(1.0%;2/201)被判定为腔内吻合口非微小病变(7 - 8 mm息肉)阳性,经结肠镜检查确诊,但组织病理学检查为非肿瘤性病变。在光学结肠镜检查中,10.0%(20/201)的吻合口被判定为异常和/或进行了活检,仅发现1个非微小良性肿瘤(7 mm管状腺瘤)。
我们低风险队列中缺乏腔内癌复发情况,无法评估检测敏感性,使得本研究在这方面的效能不足。未评估联合CT/CT结肠成像相对于标准CT/结肠镜检查方法可能节省的成本。
在低风险队列中,结直肠癌切除术后1年时,相关的腔内吻合口病理情况似乎非常少见。与结肠镜检查不同,诊断性对比增强CT结肠成像能有效评估吻合口的腔内和壁外情况。见视频摘要:http://links.lww.com/DCR/A471 。